4th Quarter - Termination

KLINK CAMPAIGNS, INC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

Firm
Client
Income
—
Expenses
—
Terminated
Dec 30, 2022

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 24, 2023 — Replaced
4th Quarter - Termination (this page) Apr 17, 2023 — Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicaid & Medicare COVID-19 Research and development of biopharmaceuticals

LobbyistCovered position, as disclosed
FRANK J HOWARD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Economics/Economic Development ECN

Economic impact of the biopharmaceutical industry Research and development of biopharmaceuticals Inflation Reduction Act

LobbyistCovered position, as disclosed
FRANK J HOWARD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.